Solara Active Pharma Sciences Limited Share Price and Company Fundamentals
Last traded: Yesterday at 10:00 AM
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Key Metrics
PE ratio
-
PB ratio
1.50
Dividend yield
-
Beta
0.89
Market cap
₹21.26B
Enterprise value
₹25.77B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 1775 |
| Website | https://www.solara.co.in |
| Mailing address | TICEL BIO PARK 6th floor Module No. 601, 602, 603, Phase II CSIR Road Taramani Chennai 600113 India |
| Phone / Fax | 91 44 4344 6700 / 91 44 4740 6190 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Solara Active Pharma Sciences Limited paid ₹- dividend and the ex-dividend date was 18 Aug 2021.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SOLARA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Solara Active Pharma Sciences Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Sandeep Shashikantha Rao M.Sc., PGDM | CEO & MD | 52 | |
| Mr. Arun Kumar Pillai B.Com. | Founder & Non-Executive Director | 64 | |
| Mr. Sarat Kumar | Chief Financial Officer & Chief Investor Relations Officer | ||
| Mr. Vishal Mathur | Chief Commercial Officer | ||
| Mr. Raghavan Venkatramani | General Manager of Accounts | ||
| Dr. Hero Velladurai | Chief Scientific Officer | ||
| Ms. Pooja Jaya Kumar | Company Secretary & Compliance Officer | ||
| Mr. Mohanraj S | Additional Executive Director & Chief Human Resources Officer | ||
| Mr. V. Sundara Moorthy | Chief Quality Officer | ||
| Mr. Rajesh Patro | Chief Risk Officer |
Profitability and management effectiveness
Profit margin
-1.52%
Operating margin
3.37%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Solara Active Pharma Sciences Limited is 21.26B and its enterprise value is 25.77B. The enterprise value to revenue ratio of SOLARA is 2.05. The enterprise value to EBITDA ratio of SOLARA is 15.30.
The SOLARA's stocks Beta value is 0.89 making it 11% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Solara Active Pharma Sciences Limited (NSE:SOLARA) Frequently Asked Questions
1. What is Solara Active Pharma Sciences Limited's Stock Symbol?
Solara Active Pharma Sciences Limited trades on NSE under the ticker symbol "SOLARA".
2. What is Solara Active Pharma Sciences Limited's stock price today?
One share of SOLARA stock can currently be purchased for approximately ₹441.25.
3. How can I contact Solara Active Pharma Sciences Limited?
Solara Active Pharma Sciences Limited's mailing address is TICEL BIO PARK 6th floor Module No. 601, 602, 603, Phase II CSIR Road Taramani Chennai 600113 India. The company can be reached via phone at 91 44 4344 6700.
4. What is Solara Active Pharma Sciences Limited's official website?
The official website of Solara Active Pharma Sciences Limited is https://www.solara.co.in.